Chronic oxidative stress leads to malignant transformation along with acquisition of stem cell characteristics, and epithelial to mesenchymal transition in human renal epithelial cells

Journal of Cellular Physiology

Volumn 230, Issue 8, 2015, Pages 1916-1928

  Mahalingaiah, Prathap Kumar S ^a   Ponnusamy, Logeswari ^a   Singh, Kamaleshwar P ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; SMALL INTERFERING RNA;

ADULT; ARTICLE; CARCINOGENICITY; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STEM CELL; UPREGULATION; ANIMAL; CANCER STEM CELL; CELL LINE; CELL TRANSFORMATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; KIDNEY; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; XENOGRAFT;

MUS MUSCULUS;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HETEROGRAFTS; HUMANS; KIDNEY; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84928388291     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24922     Document Type: Article

References (68)

1. Alarifi S . 2011. Assessemnt of MCF-7 cells as an invitro model system for evaluation of chemical oxidative stressors. Afr J Biotechnol 10:3872-3879.
2. Axelson H, Johansson ME . 2013. Renal stem cells and their implications for kidney cancer. Semin Cancer Biol 23:56-61.
3. Baldwin AS . 2001. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107:241-246.
4. Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV . 2003. Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci U S A 100:3913-3918.
5. Bjørge T, Tretli S, Engeland A . 2004. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160:1168-1176.
6. Block K, Gorin Y, Hoover P, Williams P, Chelmicki T, Clark RA, Yoneda T, Abboud HE . 2007. NAD(P)H oxidases regulate HIF-2alpha protein expression. J Biol Chem 282:8019-8026.
7. Bussolati B, Bruno S, Grange C, Ferrando U, Camussi G . 2008. Identification of a tumor-initiating stem cell population in human renal carcinomas. FASEB J 22:3696-3705.
8. Bussolati B, Dekel B, Azzarone B, Camussi G . 2013. Human renal cancer stem cells. Cancer Lett 338:141-146.
9. Cannito S, Novo E, Compagnone A, Valfrè di Bonzo, Busletta L, Zamara C, Paternostro E, Povero C, Bandino D, Bozzo A, Cravanzola F, Bravoco C, Colombatto V, Parola S . 2008. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 29:2267-2278.
10. Chieli E, Romiti N . 2008. Kidney proximal human tubule HK-2 cell line as a tool for the investigation of P-glycoprotein modulation by natural compounds. Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas 7:281-294.
11. Cho D, Signoretti S, Regan M, Mier JW, Atkins MB . 2007. The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer. Clin Cancer Res 13(2 Pt 2) 758s-763s.
12. Dayem AA, Choi HY, Kim JH, Cho SG . 2010. Role of oxidative stress in stem, cancer, and cancer stem cells. Cancers (Basel) 2:859-884.
13. Deev IE, Polianovskii OL . 2004. [oct-genes and oct-proteins]. Mol Biol (Mosk) 38:48-55.
14. Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C . 2001. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res 61: 5911-5918.
15. Eliceiri BP, Klemke R, Strömblad S, Cheresh DA . 1998. Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 140:1255-1263.
16. Fink JC, Brown J, Hsu VD, Seliger SL, Walker L, Zhan M . 2009. CKD as an underrecognized threat to patient safety. Am J Kidney Dis 53:681-688.
17. Fisher R, Gore M, Larkin J . 2013. Current and future systemic treatments for renal cell carcinoma. Semin Cancer Biol 23:38-45.
18. Gago-Dominguez M, Castelao JE . 2006. Lipid peroxidation and renal cell carcinoma: Further supportive evidence and new mechanistic insights. Free Radic Biol Med 40:721-733.
19. Gago-Dominguez M, Castelao JE, Yuan JM, Ross RK, Yu MC . 2002. Lipid peroxidation: A novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 13:287-293.
20. Ganie SA, Hamid HE, Masood A, Zargar A . 2011. Long dose exposure of hydrogen peroxide (H2O2) in albino rats and effect of Podophyllum hexandrum on oxidative stress. Eur Rev Med Pharmacol Sci 15:906-915.
21. Gautier JC, Holzhaeuser D, Markovic J, Gremaud E, Schilter B, Turesky RJ . 2001. Oxidative damage and stress response from ochratoxin a exposure in rats. Free Radic Biol Med 30:1089-1098.
22. Ghaffari S . 2008. Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox Signal 10:1923-1940.
23. Giannoni E, Bianchini F, Masieri L, Serni S, Torre E, Calorini L, Chiarugi P . 2010. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 70:6945-6956.
24. Giannoni E, Parri M, Chiarugi P . 2012. EMT and oxidative stress: A bidirectional interplay affecting tumor malignancy. Antioxid Redox Signal 16:1248-1263.
25. Greenland S, Gago-Dominguez M, Castelao JE . 2004. The value of risk-factor ("black-box") epidemiology. Epidemiology 15:529-535.
26. Gupta S, Verfaillie C, Chmielewski D, Kren S, Eidman K, Connaire J, Heremans Y, Lund T, Blackstad M, Jiang Y, Luttun A, Rosenberg ME . 2006. Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol 17:3028-3040.
27. Hajjar I, Kotchen TA . 2003. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290:199-206.
28. Hamza SM, Dyck JR . 2014. Systemic and renal oxidative stress in the pathogenesis of hypertension: Modulation of long-term control of arterial blood pressure by resveratrol. Front Physiol 5:292.
29. Hwang SL . 2008. Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells. J Agric Food Chem 56:859-864.
30. Kim FJ, Campagna A, Khandrika L, Koul S, Byun SS, vanBokhoven A, Moore EE, Koul H . 2008. Individualized medicine for renal cell carcinoma: Establishment of primary cell line culture from surgical specimens. J Endourol 22:2361-2366.
31. Koul H, Huh JS, Rove KO, Crompton L, Koul S, Meacham RB, Kim FJ . 2011. Molecular aspects of renal cell carcinoma: A review. Am J Cancer Res 1:240-254.
32. Lankin VZ, Sherenesheva NI, Konovalova GG, Tikhaze AK . 2000. Beta-carotene-containing preparation carinat inhibits lipid peroxidation and development of renal tumors in rats treated with chemical carcinogen. Bull Exp Biol Med 130:694-696.
33. Lee JM, Dedhar S, Kalluri R, Thompson EW . 2006. The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 172:973-981.
34. Linehan WM, Gnarra JR, Lerman MI, Latif F, Zbar B . 1993. Genetic basis of renal cell cancer. Important Adv Oncol 47-70.
35. Linehan WM, Ricketts CJ . 2013. The metabolic basis of kidney cancer. Semin Cancer Biol 23:46-55.
36. Liu M, Okada S . 1994. Induction of free radicals and tumors in the kidneys of Wistar rats by ferric ethylenediamine-N, N'-diacetate. Carcinogenesis 15:2817-2821.
37. Livak KJ, Schmittgen TD . 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
38. Maher ER . 2013. Genomics and epigenomics of renal cell carcinoma. Semin Cancer Biol 23:10-17.
39. Mancini V, Battaglia M, Ditonno P, Palazzo S, Lastilla G, Montironi R, Bettocchi C, Cavalcanti E, Ranieri E, Selvaggi FP . 2008. Current insights in renal cell cancer pathology. Urol Oncol 26:225-238.
40. Mandel JS, McLaughlin JK, Schlehofer B, Mellemgaard A, Helmert U, Lindblad P, McCredie M, Adami HO . 1995. International renal-cell cancer study. IV. Occupation. Int J Cancer 61:601-605.
41. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA . 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
42. McLaughlin JK, Lipworth L . 2000. Epidemiologic aspects of renal cell cancer. Semin Oncol 27:115-123.
43. Moch H . 2013. An overview of renal cell cancer: Pathology and genetics. Semin Cancer Biol 23:3-9.
44. Navai N, Wood CG . 2012. Environmental and modifiable risk factors in renal cell carcinoma. Urol Oncol 30:220-224.
45. Ogasawara MA, Zhang H . 2009. Redox regulation and its emerging roles in stem cells and stem-like cancer cells. Antioxid Redox Signal 11:1107-1122.
46. Okamoto K, Toyokuni S, Uchida K, Ogawa O, Takenewa J, Kakehi Y, Kinoshita H, Hattori-Nakakuki Y, Hiai H, Yoshida O . 1994. Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int J Cancer 58:825-829.
47. Ozbek E . 2012. Induction of oxidative stress in kidney. Int J Nephrol 2012:465897.
48. Paganini-Hill A, Chao A, Ross RK, Henderson BE . 1989. Aspirin use and chronic diseases: A cohort study of the elderly. BMJ 299:1247-1250.
49. Parent ME, Hua Y, Siemiatycki J . 2000. Occupational risk factors for renal cell carcinoma in Montreal. Am J Ind Med 38:609-618.
50. Pesce M, Schöler HR . 2001. Oct-4: Gatekeeper in the beginnings of mammalian development. Stem Cells 19:271-278.
51. Ratajczak MZ, Machalinski B, Wojakowski W, Ratajczak J, Kucia M . 2007. A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues. Leukemia 21:860-867.
52. Schlehofer B, Pommer W, Mellemgaard A, Stewart JH, McCredie M, Niwa S, Lindblad P, Mandel JS, McLaughlin JK, Wahrendorf J . 1996. International renal-cell-cancer study. VI. the role of medical and family history. Int J Cancer 66:723-726.
53. Schmalhofer O, Brabletz S, Brabletz T . 2009. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28:151-166.
54. Small DM, Coombes JS, Bennett N, Johnson DW, Gobe GC . 2012. Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton) 17:311-321.
55. Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, Stark PC, Uhlig K, Van Lente F, Levey AS . 2005. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: Evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol 16:2439-2448.
56. Sung CC, Hsu YC, Chen CC, Lin YF, Wu CC . 2013. Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease. Oxid Med Cell Longev 2013:301982.
57. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE . 2005. Oct4 expression in adult human stem cells: Evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26:495-502.
58. Thoenes W, Störkel S, Rumpelt HJ . 1986. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181:125-143.
59. Tiezzi DG, Fernandez SV, Russo J . 2007. Epithelial mesenchymal transition during the neoplastic transformation of human breast epithelial cells by estrogen. Int J Oncol 31:823-827.
60. Tokar EJ, Qu W, Liu J, Liu W, Webber MM, Phang JM, Waalkes MP . 2010. Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst 102:638-649.
61. Valente MJ, Henrique R, Costa VL, Jerónimo C, Carvalho F, Bastos ML, de Pinho PG, Carvalho M . 2011. A rapid and simple procedure for the establishment of human normal and cancer renal primary cell cultures from surgical specimens. PLoS One 6:e19337.
62. Wang D, Kreutzer DA, Essigmann JM . 1998. Mutagenicity and repair of oxidative DNA damage: Insights from studies using defined lesions. Mutat Res 400:99-115.
63. Waris G, Ahsan H . 2006. Reactive oxygen species: Role in the development of cancer and various chronic conditions. J Carcinog 5:14.
64. Welford SM, Dorie MJ, Li X, Haase VH, Giaccia AJ . 2010. Renal oxygenation suppresses VHL loss-induced senescence that is caused by increased sensitivity to oxidative stress. Mol Cell Biol 30:4595-4603.
65. Wilcox CS . 2005. Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension. Am J Physiol Regul Integr Comp Physiol 289:R913-935.
66. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME . 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
67. Xu Y, Li Y, Pang Y, Ling M, Shen L, Yang X, Zhang J, Zhou J, Wang X, Liu Q . 2012. EMT and stem cell-like properties associated with HIF-2alpha are involved in arsenite-induced transformation of human bronchial epithelial cells. PLoS One 7:e37765.
68. Zhang A, Jia Z, Guo X, Yang T . 2007. Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am J Physiol Renal Physiol 293:F723-731.